For healthcare executives, hospital administrators, and policymakers, the fundamental challenge of the 21st century healthcare system is clear: how to improve patient outcomes and control costs simultaneously. The traditional fee-for-service model, which rewards volume, is widely seen as unsustainable and misaligned with these goals. The solution is the global transition to value-based care (VBC) —a healthcare delivery model in which providers are paid based on patient health outcomes, not the quantity of services they deliver. However, making this shift successfully requires a new technological infrastructure capable of measuring, analyzing, and improving performance. This is the domain of value-based care (VBC) technology. A new, comprehensive study from Global Leading Market Research Publisher QYResearch provides a definitive outlook on this nascent but rapidly evolving market. The report, “Value-based Care (VBC) Technology – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032” , offers critical intelligence for health IT vendors, provider organizations, and strategic investors.
The market data reveals a sector on a steady growth path from an emerging base. According to QYResearch’s detailed market analysis, the global market for value-based care technology was valued at an estimated US$ 106 million in 2023. Looking ahead, this market is forecast to expand significantly, reaching a projected US$ 159.5 million by 2030. This represents a solid compound annual growth rate (CAGR) of 5.6% during the forecast period from 2024 to 2030. This measured industry outlook reflects the gradual but accelerating adoption of value-based care models and the corresponding need for specialized technology solutions to support them.
[Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)]
https://www.qyresearch.com/reports/2638549/value-based-care–vbc–technology
Market Analysis: Defining the Technology for Outcomes-Based Reimbursement
Value-based care technology encompasses the specialized software and hardware tools designed to enable healthcare organizations to successfully participate in value-based care contracts. Unlike traditional health IT focused on billing and documentation, VBC technology is specifically architected to measure, track, and improve patient outcomes and manage population health.
The market is segmented by the type of technology:
- Software Technology: This is the core of the VBC technology market. It includes a range of applications and platforms, such as:
- Population Health Management Platforms: Tools that aggregate and analyze clinical, claims, and other data for defined patient populations to identify high-risk patients, track quality measures, and manage care interventions.
- Analytics and Reporting Solutions: Software that calculates performance against value-based care quality and cost metrics, generates reports for payers, and provides insights for improvement.
- Care Coordination and Patient Engagement Tools: Applications that facilitate communication and collaboration among care teams and with patients, including secure messaging, remote monitoring, and patient portals.
- Clinical Decision Support (CDS) Tools: Advanced CDS that specifically guides clinicians towards evidence-based, cost-effective care choices aligned with VBC goals.
- Hardware Technology: This includes specialized devices that support VBC models, such as:
- Remote Patient Monitoring (RPM) Devices: Wearables and home-based sensors (e.g., blood pressure cuffs, glucose monitors, weight scales) that transmit patient health data directly to care teams, enabling proactive management of chronic conditions outside of traditional clinical settings.
- Point-of-Care Diagnostic Devices: Tools that enable rapid, decentralized testing, facilitating timely clinical decisions and reducing unnecessary referrals or hospital visits.
These technologies find critical application across a range of healthcare settings:
- Hospitals: Used to manage patient populations across the care continuum, reduce readmissions, and improve performance in value-based purchasing programs.
- Nursing Centers and Post-Acute Care Facilities: Essential for coordinating care transitions, preventing complications, and managing patients with complex, chronic conditions.
- Other: Including physician practices, accountable care organizations (ACOs), and payer organizations.
The Three Pillars of Market Development
As a 30-year veteran of industry analysis, I see the value-based care technology market being shaped by three powerful, interlocking forces.
1. The Global Policy and Payer Shift Towards Value-Based Reimbursement:
This is the single most powerful and fundamental driver. Governments and private insurers worldwide are increasingly moving away from fee-for-service and implementing value-based payment models. In the U.S., the Centers for Medicare & Medicaid Services (CMS) has set ambitious goals to have the majority of Medicare payments tied to value or quality. Similar trends are underway in Europe and other regions. This shift creates a direct and urgent need for providers to acquire the technology necessary to succeed under these new payment models. Without the analytics and reporting capabilities of VBC technology, providers are effectively flying blind in value-based contracts.
2. The Need to Manage Population Health and Reduce Costs:
At the heart of value-based care is the proactive management of patient populations to keep them healthy and prevent costly acute episodes. This requires a fundamentally different approach than the reactive, visit-based model of fee-for-service. VBC technology provides the tools for this new approach. Population health platforms allow providers to identify patients at high risk of hospitalization, deploy care management resources effectively, and track the impact of interventions. Remote patient monitoring devices extend the reach of care teams into patients’ homes, enabling early detection of problems and preventing complications. This ability to manage health proactively, not just treat illness reactively, is the core value proposition of VBC technology.
3. The Requirement for Advanced Data Analytics and Interoperability:
VBC models are data-intensive. They require the integration and analysis of clinical data from EHRs, claims data from payers, and increasingly, patient-generated data from remote monitoring devices. Sophisticated analytics are needed to calculate risk scores, track quality measures, and attribute patients to providers. Furthermore, interoperability—the ability to seamlessly share data across different systems and organizations—is critical for coordinating care across the multiple providers a patient may see. VBC technology platforms are purpose-built to tackle these data challenges, providing the analytics engine and interoperability layer that traditional EHRs often lack.
Competitive Landscape and Strategic Implications
The competitive landscape for value-based care technology is currently characterized by a dynamic group of specialized, innovative companies, rather than a few dominant giants. Key players identified by QYResearch include Etyon Health, Hindsait, Aver, Biome Analytics, SiftMD, M&S Biotics, EHealthAnalytics, LifeWIRE Corp, and LucidAct Health Inc. These companies focus on specific niches within the VBC technology space, such as analytics for specific conditions, care coordination platforms, or remote patient monitoring solutions. As the market matures, we can expect to see consolidation and the entry of larger health IT and technology companies seeking to expand their value-based care offerings. Success in this market requires deep domain expertise, strong analytics capabilities, and the ability to demonstrate a clear return on investment by improving outcomes and reducing costs.
In conclusion, the value-based care technology market, while still emerging, is poised for steady and significant growth. Its projected 5.6% CAGR reflects the fundamental, long-term shift in global healthcare towards paying for value, not volume. For industry leaders and investors, this market represents a compelling opportunity to provide the essential tools that will enable this transformation, improving the quality and efficiency of healthcare for populations worldwide.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
